← Timeline

BE · The Open Circuit — Multi-Analyst Outlook 2026–2031

BE · Oct 24, 2026 · Analysis · Claude

⇆ Compare
BE$193.30▼ 45% off Jun 25 ’26 high52-wk $75.70 – $351.28As of Oct 24, 2026

Independent analysis of BE — “BE · The Open Circuit — Multi-Analyst Outlook 2026–2031”, published Oct 24, 2026 as part of Stock Timelines, a running journal of independent equity research. Featuring consensus target $285, projected target $295 (5y).

Key Research Takeaways: BE · The Open Circuit — Multi-Analyst Outlook 2026–2031

Tickers Analyzed
BE
Consensus Price Target
$285
Projected Price Target (5y)
$295
Spot Price at Analysis
$193.3 (▼ 45% off Jun 25 ’26 high)
52-Week Range
$75.7 - $351.28
Publication Date
Oct 24, 2026
Research Provider
Claude
01 · Equity deep-dive — synthesized analyst desk
BE
$193.30 ▼ 45% off Jun 25 ’26 high
NYSE · SOLID-OXIDE FUEL CELLSMKT CAP ≈ $57B52-WK $75.70 – $351.28AS OF OCT 23, 2026 CLOSE

The voltage has never been higher. The current hasn’t followed.

Revenue is up 138%, operating margin is 23%, and guidance has been raised three times — yet operating cash flow turned negative and the stock fell 11% on the print. The market is pricing one question: is the ~$20B backlog an annuity of AI power demand, or a set of options on data centers that can slip? Six analyst lenses, three scenarios, four time horizons.

The verdict · TL;DR
Bloom is executing flawlessly on the income statement and unproven on the cash statement. Q3 beat on every margin line, but free cash flow was −$181M as contract assets absorbed cash, and the two named anchor projects (Oracle, AEP) have already moved right. Even after a 45% drawdown the stock trades near 40x forward earnings. The setup is asymmetric but fragile: the bull needs the backlog to convert, the bear only needs it to slip.
5-yr · prob-weighted
$296
+53% vs $193.30
52-week playback · where the tape sits❚❚ Mid-range, post-print gap down
$193.30 · Oct 23, 2026 closeconsensus $285 · +48%
$75.70 · 52-wk low · Dec 17 ’25$351.28 · 52-wk high · Jun 25 ’26
Price history + cone of outcomes · Nov 2024 → 2031
HISTORICALBULLBASEBEARPROB-WTD
$10$20$40$80$160$320$640 Nov’24May’25Nov’25May’2620272028202920302031 $351 ATH · Jun 25 ’26 $76 low · Dec 17 ’25 $240$260$272 $572$295$68 PW $296 TODAY · $193.30

Gray line = month-end closes with the dated June 2026 high and December 2025 low; colored paths = synthesized scenario midpoints forward, probability-weighted (bear 30% · base 45% · bull 25%, bear-tilted because of project-slippage and AI-sentiment risk). Log price axis, mid-year marks. Clay open circle = Street 12-month consensus ≈ $285 (range $176–$351, 29 analysts, Buy). Month-end closes are from a public price-history table, so intramonth swings are smoothed except the two dated markers.

Re-weight the scenarios

Those probabilities are a judgment call — so make them yours. Drag to set how likely the bear and bull cases are (base takes the remainder); the blended target, the dotted line on the chart, and the prob-weighted row of the scenario cards update live.

30% bear45% base25% bull
Blended 5-yr expected$296+53% vs $193.30
+138%
Q3’26 Revenue ($1.236B)
23.1%
Non-GAAP Op. Margin (8.9% yr ago)
$0.94
Non-GAAP EPS vs. $0.69 est.
$299M
Adj. EBITDA (24% margin)
34.5%
Non-GAAP Gross Margin
−$181M
Q3 Free Cash Flow (+$42M YTD)
$2.5B
Cash at Quarter End
$4.4–4.6B
FY26 Revenue Guide (3rd raise)
02 · The panel — six ways to read the same tape

Six analyst lenses, six answers

The same Q3 print supports targets from $86 to $330 depending on which framework you trust. Each lens is a synthesized perspective with its own 12-month target; the panel mean is $203 against a Street consensus near $285.

Growth / Momentum PM

The Backlog Compounder

Three raises in 2026, operating income in Q3 alone above all of 2025, and Morgan Stanley now models 2.1 GW shipped in 2027 and 3.7 GW in 2028. Capacity is a dial, and demand is turning it up.

12-MO TARGET $330 · ~50x NTM EPS $6.66 · high conviction
Value / FCF Analyst

The Cash Skeptic

A $57B market cap against $42M of year-to-date free cash flow is not a value stock. Capex has already run four times all of 2025 and contract assets are absorbing cash. Pay for cash, not for backlog.

12-MO TARGET $140 · ~27x 2027E EPS $5.15 · medium conviction
AV-style Disruption Skeptic

The Slippage Thesis

Oracle and AEP timelines have already moved, the backlog has not been updated since February, and short sellers question its quality. Orders that can slip can also be cancelled.

12-MO TARGET $86 · ~22x bear NTM EPS $3.90 · medium conviction
Moat / Competitive Analyst

The Time-to-Power Case

Sub-90-day deployment, on-site solid-oxide units with carbon-capture readiness, and a 700 MW AEP award for Google make Bloom the one supplier that gets power on when the grid cannot.

12-MO TARGET $265 · ~40x NTM EPS $6.66 · medium-high conviction
Quant / Technical

The Broken Trend

Below the 200-day average, 45% off the June high, and a 15%-a-day-type volatility profile (beta near 3.8). A re-test of the pre-print $218 close is the base technical case.

12-MO TARGET $215 · ~32x NTM EPS $6.66 · low conviction
Macro / Sector Strategist

The Rates Tourist

Surging Treasury yields and a faltering AI-capex tape hit long-duration power names first. Fundamentals are intact, but the multiple belongs to the rate cycle for now.

12-MO TARGET $180 · ~27x NTM EPS $6.66 · low conviction
03 · Wall Street’s read

Wall Street 12-month price targets

What the sell-side expects over the next year. Bars are sorted low to high; the dashed line is today’s $193.30 — every target shown sits above it, even after Friday’s cuts.

Consensus ≈ $285 (+48%) · selected names, range $176–$351
BUYHOLDSELL
Roth Capital$230Jefferies$242BTIG$250JPMorgan$292Morgan Stanley$335RBC Capital$335UBS$350Mizuho$351TODAY · $193.30

Post-print moves (Oct 23): Morgan Stanley raised to $335, JPMorgan cut to $292, BTIG to $250, Jefferies to $242, Roth to $230. RBC ($335), UBS ($350, Oct 7) and Mizuho ($351, Sep 14) are the latest levels found and may predate the print. Consensus differs by aggregator ($285 to $292); no Sell-rated firm was found among those sampled.

04 · Price scenarios — 1 / 2 / 3 / 5 years

Where the circuit closes

Every price is next-twelve-month EPS at that date times an exit multiple. Returns are vs. today’s $193.30. These are illustrative frameworks, not forecasts; five-year outcomes hinge on whether backlog converts to cash.

1 Year

Mid-2027
Bull$330+71%
Base$240+24%
Bear$78−60%
Prob-wtd$214+11%

2 Years

Mid-2028
Bull$425+120%
Base$260+35%
Bear$72−63%
Prob-wtd$245+27%

3 Years

Mid-2029
Bull$488+152%
Base$272+41%
Bear$70−64%
Prob-wtd$265+37%

5 Years

Mid-2031
Bull$572+196%
Base$295+53%
Bear$68−65%
Prob-wtd$296+53%
▸ Bull case — show the assumptions & math
Utilities treat Bloom servers as rate-based distribution assets, AEP-style carbon-capture projects repeat, capacity passes 5 GW a year, and EPS tracks Morgan Stanley-type shipment paths (2.1 GW in 2027, 3.7 GW in 2028) and beyond.
NTM EPS ≈ $22 at mid-2031 (2031E $21 / 2032E $23) × ~26× exit → $572 · CAGR from today ≈ +26%/yr
▸ Base case — show the assumptions & math
Street EPS through 2028 ($3.27 / $5.15 / $8.17), then growth fades to the low teens as the multiple compresses from ~45x NTM today toward a mature-industrial 20x.
NTM EPS ≈ $14.75 at mid-2031 (2031E $14.0 / 2032E $15.5) × ~20× exit → $295 · CAGR ≈ +9%/yr
▸ Bear case — show the assumptions & math
Hyperscaler capex digests, Oracle and AEP slip again or shrink, working capital keeps draining cash, and competing on-site power pressures price. EPS stalls near $4–6 and the stock re-rates toward where it traded in December 2025.
NTM EPS ≈ $5.65 at mid-2031 × ~12× exit → $68 · CAGR ≈ −20%/yr
05 · Follow the cash — where voltage meets current

Revenue, capex, free cash flow & debt ($B)

The income statement is the voltage; the cash statement is the current. The bull and bear theses both live in the gap between the sky bar and the olive bar.

Annual revenue, capex, FCF & total debt · 2023 → 2026E
REVENUECAPEXFREE CASH FLOWTOTAL DEBT
−$1B$0B$1B$2B$3B$4B$5B 2023202420252026E

Revenue: $1.33B / $1.47B / $2.02B, then the $4.4–4.6B guide midpoint ($4.5B) for 2026E. FCF swung from −$456M (2023) to +$33M and +$57M, and is +$42M year-to-date after a −$181M Q3. Capex ($84M / $59M / $57M) is $231M through Q3, four times all of 2025; the 2026E capex ($0.38B) and FCF ($0.15B) bars are desk estimates (faded) and total debt is held at roughly $3.0B. Debt includes leases; with $2.5B of cash, net debt is only about $0.5B, funded largely by the 2025 convertible issuance. The Q3 cash gap is mostly contract assets (−$430M).

06 · Earnings power

EPS path underpinning the targets ($)

Each target is an EPS estimate times an exit multiple. This is the earnings ladder the scenarios are built on.

Adjusted EPS · reported vs. estimated, 2025 → 2032E
REPORTEDESTIMATE
$0$4$8$12$16 $0.762025$3.272026E$5.152027E$8.172028E$10.402029E$12.302030E$14.002031E$15.502032E

Non-GAAP EPS. 2026E $3.27 sits just above the raised $3.10–$3.40 guide; 2027E $5.15 and 2028E $8.17 are Street averages (TIKR, Oct 23, 2026). 2029E–2032E are desk extrapolations beyond Street coverage, fading growth from ~27% to ~11%. At $193.30 the stock is about 37x 2027E and 24x 2028E; GAAP EPS ($0.78 in Q3) is lower, and trailing P/E on GAAP is above 130x.

07 · Growth scorecard

The business is still growing

Q3 FY26, year-over-year — read these against a stock that just lost 11% on the print.

Year-over-year growth by metric · Q3 FY26
REVENUE LINESPROFIT LINES
Service revenue+15%Installation revenue+29%Total revenue+138%Product revenue+179%Non-GAAP op. income+517%Non-GAAP EPS+527%

Bloom reports no AI-segment split, so the frontier color marks the profit lines that show operating leverage: operating expenses grew 26% while revenue grew 138%. Service revenue ($67.6M, +15%) and installation ($84.9M, +29%) are the slow core; product revenue crossed $1B for the first time. Profit growth is off a small year-ago base ($0.15 EPS, $46M operating income).

08 · The debate

Bull vs. Bear

The valuation argument compresses into one disagreement: does Bloom’s backlog convert into cash on schedule, or does it slip like Oracle and AEP?

▲ THE BULL CASE

  • Operating leverage is real. Q3 operating margin 23.1% vs 8.9%; Q3 operating income alone topped all of 2025.
  • Three guidance raises in 2026. Revenue now $4.4–4.6B (+122%) and EPS $3.10–3.40, up from $2.55–2.85.
  • Named anchor demand. Oracle 1.2 GW contracted, AEP 700 MW for Google, Nebius 300 MW, and a Brookfield framework expanded from $5B to $25B.
  • Capacity is a dial. Fremont is doubling to 2 GW and expanding toward 5 GW; Morgan Stanley models 3.7 GW shipped in 2028.
  • Balance sheet funds the build. $2.5B of cash, S&P 500 inclusion, and year-to-date free cash flow still positive.
  • The multiple already reset. About 78x to 40x forward earnings in under a month while estimates rose.

▼ THE BEAR CASE

  • Cash is not following earnings. Q3 operating cash flow −$27M and FCF −$181M; contract assets grew about $430M.
  • Anchor projects are slipping. Oracle reportedly sent a force-majeure notice on a New Mexico site; AEP’s timeline moved to no later than 2030.
  • Backlog is opaque. The ~$20B figure was last updated in February, and Jefferies cut its target citing no update on the Oracle opportunity.
  • Capex is ramping. $231M year-to-date is four times 2025, before a Fremont expansion.
  • Sentiment beta. A beta near 3.8 means AI-capex scares hit Bloom roughly three to four times as hard as the market.
  • Legal overhang. A securities class action over China-linked scandium sourcing, following a July short-seller report; allegations are unproven.
09 · Risk map

Risk map — likelihood × impact

Where each risk sits, not just how big it is. The hot upper-right corner is likely and high-impact; the project-specific risks cluster one row down in “possible.”

Low impact
Medium impact
High impact
Likely
  • Margin ramp drag
  • Working-capital drag
  • Multiple de-rating
Possible
  • Securities suits
  • Capacity overbuild
  • Rival power tech
  • Project slippage
  • Backlog quality
Tail
  • Hyperscaler pullback

Multiple de-rating

Likely × High

A stock with a beta near 4 trades on AI-capex sentiment; 78x to 40x forward P/E in three weeks shows how fast the multiple can move.

Project slippage

Possible × High

Oracle reportedly issued a force-majeure notice on a New Mexico site; AEP moved its target from 2028 to no later than 2030.

Backlog quality

Possible × High

The roughly $20B backlog was last updated in February and is partly backstopped by customers who can walk away.

Hyperscaler pullback

Tail × High

Oracle has run negative free cash flow; a financing squeeze at one anchor customer could cancel gigawatts of orders at once.

Working-capital drag

Likely × Medium

Q3 contract assets rose about $430M, turning operating cash flow to −$27M; management calls it not a trend.

Capacity overbuild

Possible × Medium

Fremont is being expanded toward 5 GW a year; if demand dials down, fixed cost lands on margins.

Rival power tech

Possible × Medium

Turbines, engines and batteries compete for the same on-site megawatts; GE Vernova trades near the same forward multiple.

Margin ramp drag

Likely × Low

New lines and expedited deliveries held gross margin near 34% despite higher volume; BTIG flagged near-term drag.

Securities suits

Possible × Low

A class action over China-linked scandium sourcing disclosures was filed after a July 2026 short-seller report; allegations are unproven.

10 · Plain-language glossary

The jargon, decoded

Hover the dotted terms in the metrics, or scan the desk’s working definitions here.

Solid-oxide fuel cell
A device that makes electricity from natural gas or hydrogen through a chemical reaction instead of combustion. Bloom calls its units Energy Servers.
Behind the meter
Power generated on the customer’s own site rather than bought from the grid — the reason data centers buy from Bloom.
Contract assets
Revenue recognized before the customer has paid. They rose about $430M in Q3, which is why cash lagged earnings.
Backlog
Contracted work not yet delivered. Bloom’s ~$20B was last updated in February, and some of it can be cancelled.
Non-GAAP EPS
Earnings per share excluding stock compensation and one-offs. Q3 was $0.94 vs $0.78 on a GAAP basis.
Forward P/E
Price divided by expected next-twelve-month EPS. About 40x here; Bloom’s EV/EBITDA is not used because converts and leases blur leverage.
Exit multiple
The P/E assumed at the end of the forecast. Multiply it by projected EPS to get a target price.
Prob-weighted
Each scenario’s price times its probability, summed into one expected value across bear, base and bull.
NOT FINANCIAL ADVICE

Sources & method: Bloom Energy Q3 2026 8-K Exhibit 99.1 and call transcript (Oct 22, 2026); Q1/Q2 2026 releases; stockanalysis.com and kalkinemedia (annual financials, 2023–2025); TIKR and Yahoo/GuruFocus (Street EPS, call detail); TheStreet, Benzinga/Stocktwits, Defense World, Investing.com, TipRanks (price targets, Oct 23, 2026); digrin.com monthly closes and dated news for price history; Google Finance and Investing.com (Oct 23 close, 52-week range). Prices as of Oct 23, 2026 close ($193.30). Where sources conflict I note it: market cap is about $57B on 294.5M shares (some aggregators still show a stale $64B); consensus target runs $285–$292 by aggregator. Debt is gross including leases; 2026E capex, FCF and debt bars and 2029E–2032E EPS are desk estimates. Oracle and securities-suit items come from secondary news and short-seller research and are unproven. The six “analyst lenses” are synthesized frameworks, not real people or real firm ratings. Scenario prices are illustrative midpoints, not forecasts. Not financial advice — do your own research and consider consulting a licensed financial advisor.